Cargando…
Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
[Image: see text] Escherichia coli Nissle 1917 (EcN) is a probiotic bacterium, commonly employed to treat certain gastrointestinal disorders. It is fast emerging as an important target for the development of therapeutic engineered bacteria, benefiting from the wealth of knowledge of E. coli biology...
Autores principales: | Kan, Anton, Gelfat, Ilia, Emani, Sivaram, Praveschotinunt, Pichet, Joshi, Neel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813132/ https://www.ncbi.nlm.nih.gov/pubmed/33301298 http://dx.doi.org/10.1021/acssynbio.0c00466 |
Ejemplares similares
-
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019) -
Periplasmic stress contributes to a trade-off between protein secretion and cell growth in Escherichia coli Nissle 1917
por: Emani, Sivaram Subaya, et al.
Publicado: (2023) -
Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917
por: Gelfat, Ilia, et al.
Publicado: (2022) -
Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017) -
Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)